These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36479836)
1. Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis. Ding L; Wang X; Deng X; Xia W; Wang K; Yu X; Huang Y; Wang J Cancer Med; 2023 Mar; 12(6):7019-7028. PubMed ID: 36479836 [TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis. Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832 [TBL] [Abstract][Full Text] [Related]
3. Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer. Ke ZB; Chen H; Chen JY; Cai H; Lin YZ; Sun XL; Huang JB; Zheng QS; Wei Y; Xue XY; Xu N Clin Nutr; 2021 Dec; 40(12):5792-5801. PubMed ID: 34775222 [TBL] [Abstract][Full Text] [Related]
4. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study. Wu J; Cheng X; Yang H; Xiao S; Xu L; Zhang C; Huang W; Jiang C; Wang G Int Urol Nephrol; 2024 May; 56(5):1627-1637. PubMed ID: 38177927 [TBL] [Abstract][Full Text] [Related]
5. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer. Liu P; Chen S; Gao X; Liang H; Sun D; Shi B; Zhang Q; Guo H Front Immunol; 2022; 13():1032907. PubMed ID: 36225922 [TBL] [Abstract][Full Text] [Related]
6. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study. Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695 [TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries. Liu L; Li K; Wang SG; Wang J; Yao Z; Xie Y; Ji Z; Chen Z; Hu H; Chen H; Hu J; Hou Y; Liu Z; Li Y; Ding Y; Kuang Y; Xun Y; Hu J; Zhang J; Li H; Chong T; Bi J; Wang Z; Wang Y; Zhang P; Wei Q; Chen Z; Li L; Huang J; Liu Z; Chen K; Int J Surg; 2024 Sep; 110(9):5641-5651. PubMed ID: 38788195 [TBL] [Abstract][Full Text] [Related]
8. Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non-muscle-invasive bladder cancer. Ye K; Xiao M; Li Z; He K; Wang J; Zhu L; Xiong W; Zhong Z; Tang Y Cancer Med; 2023 Feb; 12(4):4206-4217. PubMed ID: 36214475 [TBL] [Abstract][Full Text] [Related]
9. The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence. Zhao R; Shan J; Nie L; Yang X; Yuan Z; Xu H; Liu Z; Zhou X; Ma W; Shi H J Clin Lab Anal; 2021 Aug; 35(8):e23883. PubMed ID: 34184796 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy. Zhang S; Du J; Zhong X; Tan P; Xu H; Zhang J; Jin D; Li Y; Le W; Xiong X; Lin T; Wei Q Front Immunol; 2022; 13():1072433. PubMed ID: 36524107 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer. Katayama S; Mori K; Pradere B; Laukhtina E; Schuettfort VM; Quhal F; Motlagh RS; Mostafaei H; Grossmann NC; Rajwa P; Moschini M; Mathieu R; Abufaraj M; D'Andrea D; Compérat E; Haydter M; Egawa S; Nasu Y; Shariat SF; World J Urol; 2021 Dec; 39(12):4355-4361. PubMed ID: 34143284 [TBL] [Abstract][Full Text] [Related]
12. Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study. Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T Cancer Manag Res; 2020; 12():9471-9483. PubMed ID: 33061634 [TBL] [Abstract][Full Text] [Related]
13. Correlation analysis between preoperative systemic immune inflammation index and prognosis of patients after radical gastric cancer surgery: based on propensity score matching method. Zhaojun X; Xiaobin C; Juan A; Jiaqi Y; Shuyun J; Tao L; Baojia C; Cheng W; Xiaoming M World J Surg Oncol; 2022 Jan; 20(1):1. PubMed ID: 34980151 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study. Kim HS; Ku JH; Kim SJ; Hong SJ; Hong SH; Kim HS; Kwon TG; Cho JS; Jeon SS; Joo KJ; Ahn HJ; Park HS; Seong do H; Kwon DD; Kim HJ; Lim JS; Lee HL Yonsei Med J; 2016 Jul; 57(4):855-64. PubMed ID: 27189277 [TBL] [Abstract][Full Text] [Related]
15. The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer. Xu S; Tan S; Wu T; Gu J; Xu L; Che X Lasers Med Sci; 2020 Oct; 35(8):1695-1701. PubMed ID: 31970565 [TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259 [TBL] [Abstract][Full Text] [Related]
17. Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer. Ding L; Deng X; Xia W; Wang K; Zhang Y; Zhang Y; Shao X; Wang J Front Immunol; 2022; 13():1070043. PubMed ID: 36458001 [TBL] [Abstract][Full Text] [Related]
18. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
19. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843 [TBL] [Abstract][Full Text] [Related]
20. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis. Liu W; Zhang Y; Wang M; Wang M; Yang Q Front Oncol; 2023; 13():1229349. PubMed ID: 38023187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]